INTRODUCTION AND BACKGROUND
Excluding skin cancer, lung cancer is the second most common cancer in both men and women and approximately 14% of all new cancers are lung cancers (American Cancer Society).
Moreover, lung cancer accounts for more deaths annually than from prostate (most common cancer in men), breast (most common cancer in women), and colon cancers combined (American Cancer Society).
There are two main types of lung cancer:
• Non-small cell lung cancer (NSCLC) accounts for approximately 80 to 85% of all lung cancers and is further subdivided into adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.
• Small cell lung cancer (SCLC) accounts for approximately 10 to 15% of all lung cancers.
Unfortunately, and perhaps owing to its aggressive course and rarity relative to NSCLC, comparatively little information is available regarding SCLC in terms of its sign and symptom expression, the impact the disease has on patient lives, and well-defined treatment side effects.
Without a good understanding of these SCLC disease components, researchers are limited in their ability to develop treatments and/or clinical studies, capable of providing and/or demonstrating actual benefit to patients outside of mortality or some definition of 'clinical response'.
RESULTS
Among the 22 sign and symptom concepts, the most commonly discussed (reported in n>1 article), as described in the literature, are presented in Table 1 .
The literature review identified four main types of SCLCrelated treatments: chemotherapy, radiation/radiotherapy, biologic agents and targeted agents. A total of 106 SCLC treatment side effects were identified among these treatments.
The 20 reported SCLC-related impacts were organized into the following domains:
Fourteen SCLC treatments were selected for review (Table 2) • Primary endpoints included response rates and duration, overall survival, time to progression, and objective response. • Among the 13 PRO questionnaires referenced, the following concepts were assessed most frequently: Diarrhea (n=5); fatigue (n=5); loss of appetite (n=5); quality of life (n=5) [referenced as "overall quality of life" or specific to tiredness, nausea, shortness of breath, and lack of appetite, among others]; and pain (n=4)
DISCUSSION
The literature-based SCLC conceptual model can inform researcher decisions in two important ways:
• Specifies potential treatment target areas and the measurement concepts that characterize those areas;
and • Categorizes measurement concepts to reflect their relationship to the disease process and, therefore, their relative importance to stakeholders
The literature review revealed a total of 22 signs and symptoms, 106 side effects (14 of which were frequently discussed) associated with the studied treatments, and 20 impacts in SCLC which strongly suggests that SCLC patients could benefit in a number of ways from effective treatments.
• From a symptom perspective, fatigue, pain, cough, dyspnea, hemoptysis, loss of appetite/anorexia, and weight loss were the most frequently discussed in the literature.
• Though results from the review of regulatory and associated documents suggest that concepts addressed by current SCLC treatments are relevant to the disease (e.g., diarrhea, fatigue, loss of appetite, pain, and quality of life), they also suggest that there are a wide variety of disease-related experiences that remain unexamined.
In conclusion, the information presented herein suggests that clinical researchers interested in improving the lives of patients with SCLC, have a wide variety of potential treatment targets available to them with respect to specific symptoms, impacts, and treatment-related side effects.
In terms of next steps, researchers intend to harmonize the present results with evidence collected from therapeutic area experts and patients with SCLC to further help clinical researchers make informed, evidence based decisions with respect to their treatment development programs and, specifically, study outcome measurement strategies.
GOALS AND OBJECTIVES
The purpose of this study was to characterize the primary SCLC symptoms, impacts, and treatment side effects from the perspective of available literature.
To achieve this goal, the following study objectives were specified:
• Articulate a search strategy to identify relevant literature;
• Conduct a critical review of the identified articles;
• Identify and describe the primary sign, symptom, treatment side-effect, and impact concepts that characterize SCLC from the perspective of the peerreviewed literature;
• Review FDA and/or EMA label, approval, or related research documents associated with select SCLC treatments; and
• Create a literature-centric SCLC conceptual model.
METHODS
The peer-reviewed literature was searched in February 2016 for the signs, symptoms, impacts, and treatment side effects of SCLC using MEDLINE ® , Embase, and PsycInfo ® on the OvidSP platform. Pre-identified search terms were as follows: ("small cell lung cancer" not "non-small cell lung cancer"), (sign or symptoms), ("side effects"), ("quality of life" or QoL or HRQoL or "well being" or well-being or "activities of daily living" or ADL), (2) or (3) or (4). , and (1) and (5). The search was limited to the English language, human subjects, and publishing dates of 2010 or later.
• Abstracts were retrieved and screened to identify potentially relevant articles
• Relevant articles were retrieved and reviewed in full for signs, symptoms, treatment side effects, and/or impacts of SCLC and summarized in a data extraction table
• Reference lists of articles and online resources were also searched to identify relevant articles not captured in the database search.
• Fourteen SCLC treatments were selected for label and literature review. 
Pain
Pain is a feeling triggered in the nervous system. Pain may be sharp or dull. It may come and go, or it may be constant. 1 It may occur in the back, bone, and/or chest (Ellis et al. 2014 , Riemsma et al. 2010 , Zikos et al. 2014 )
Cough
A reflex that keeps the throat and airways clear (Riemsma et al. 2010, Huber and Tufman 2012) Dyspnea An intense tightening in the chest, air hunger or a feeling of suffocation (Zikos et al. 2014, Huber and Tufman 2012) .
Hemoptysis
Coughing up blood, the spitting up of blood or bloody mucus from the lungs and throat (respiratory tract) (Riemsma et al 2010, Huber and Tufman 2012) 
Loss of appetite/ anorexia
A decreased appetite or abnormal loss of appetite for food; 5 the desire to eat is reduced (Riemsma et al. 2010 , Zikos et al. 2014 Weight loss Unexplained weight loss, or losing weight without trying (Riemsma et al. 2010, Huber and Tufman 2012) 
*Two separate Hycamtin FDA labels for each mode of administration; both oral (capsule) and injection FDA labels were reviewed. Only one label was identified for EMA which included both oral (capsule) and injection modes of administration. The original literature search identified a total of 332 articles, 25 of which were selected for full review (see Figure 1 ).
The 25 reviewed articles discussed a very wide variety of SCLC related experiences, including 22 signs and symptoms, 20 impacts, and 106 treatment-related side effects, which are presented in a preliminary SCLC conceptual model (see Figure 2 ).
• Not intended as a causal model, a conceptual model is a heuristic classification scheme that links a specified disease state or condition to its proximal and increasingly distal health outcomes (Wilson and Cleary, 1995) .
• Proximal concepts (e.g., disease signs or symptoms) tend to be uni-dimensional, have a direct relationship with the condition and effects of treatment, and targeted as primary outcomes whereas distal concepts tend to be multidimensional and indirectly related to the condition and effects of treatment (Shields et al., 2006) .
*Articles were included if they focused on the signs, symptoms, treatment side-effects, and/or impacts of SCLC and excluded if they focused on pathogenesis, genetics, or molecular biology of SCLC; on case studies of a few patients; not available in English; on non-human research; or were derived from non-peer-reviewed literature. 
